-
AdaptHealth Corp. Announces Second Quarter 2020 Financial Results
Post on 8/4/20
-
Optinose Reports Second Quarter 2020 Financial Results and Recent Operational Highlights
Post on 8/4/20
-
Advaxis Announces Common Stock Purchase Agreement for up to $20 Million with Lincoln Park Capital
Post on 8/3/20
-
PMV Pharma Closes $70 Million in Series D Financing
Post on 8/3/20
-
Merck Animal Health Completes Acquisition of Worldwide Rights to VECOXAN Brand of Parasiticides for Ruminant Portfolio
Post on 8/3/20
-
2020’s Best & Worst States for Health Care – WalletHub Study
Post on 8/3/20
-
Merck: Potential Biden Win Worrisome
Post on 8/3/20
-
Merck's Q2 Sales Got Clobbered by COVID-19, but Still Beat Estimates
Post on 8/3/20
-
Merck to Begin Pivotal COVID-19 Antiviral Studies in September
Post on 8/3/20
-
Better Buy: Gilead Sciences vs. Pfizer
Post on 8/3/20
-
3 Reasons to Buy Pfizer
Post on 8/3/20
-
Better Coronavirus Stock: Pfizer or Inovio Pharmaceuticals?
Post on 8/3/20
-
Harmony Biosciences Starts U.S. IPO Effort
Post on 8/3/20
-
Inovio Pharmaceuticals: A Focus On The HPV Pipeline Candidates
Post on 8/3/20
-
Johnson & Johnson Will Be Worth Buying After A Pullback
Post on 7/31/20
-
Johnson & Johnson's Coronavirus Vaccine Candidate Efficacious in Pre-Clinical Studies; Human Testing Has Begun
Post on 7/31/20
-
Providence Treatment Acquires Main Line Recovery
Post on 7/30/20
-
BioTelemetry Announces Sales Agent Agreement with Boston Scientific
Post on 7/30/20
-
Arbutus to Report Second Quarter 2020 Financial Results
Post on 7/29/20
-
BioTelemetry Acquires Remote Patient Monitoring Platform from Centene Subsidiary
Post on 7/29/20
-
Pfizer, BioNTech Choose Coronavirus Vaccine Candidate to Advance to Phase 2/3 Trial
Post on 7/29/20
-
How Pfizer Beat Q2 Estimates Despite Upjohn Sales Plunging 31%
Post on 7/29/20
-
Pfizer Rises 4.5% on Q2 Beats, Raised Guidance
Post on 7/29/20
-
Merck Declares Fresh Dividend; Yield Is 3.1%
Post on 7/29/20
-
Better Coronavirus Stock: Inovio vs. Vaxart
Post on 7/29/20
Philadelphia
